Last reviewed · How we verify
Aminobiphosphonate — Competitive Intelligence Brief
phase 1
Other
Small molecule
Live · refreshed every 30 min
Target snapshot
Aminobiphosphonate (Aminobiphosphonate) — Amsterdam UMC, location VUmc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Aminobiphosphonate TARGET | Aminobiphosphonate | Amsterdam UMC, location VUmc | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Aminobiphosphonate CI watch — RSS
- Aminobiphosphonate CI watch — Atom
- Aminobiphosphonate CI watch — JSON
- Aminobiphosphonate alone — RSS
Cite this brief
Drug Landscape (2026). Aminobiphosphonate — Competitive Intelligence Brief. https://druglandscape.com/ci/aminobiphosphonate. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab